Brüstle v. Greenpeace: Implications for stem cell research

Regenerative Medicine

Volumn 6, Issue 6 SUPPL., 2011, Pages 85-87

  Denoon, Alexander ^a  

^a Lawford Davies Denoon   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORPHAN DRUG;

ARTICLE; BIOTECHNOLOGICAL PROCEDURES; EMBRYO RESEARCH; EMBRYONIC STEM CELL; EUROPEAN UNION; GREENPEACE; HUMAN; HUMAN EMBRYO DESTRUCTION; LAW SUIT; MORALITY; NEURAL STEM CELL TRANSPLANTATION; ORGANIZATION; PATENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCIENTIST; STEM CELL RESEARCH; TOTIPOTENT STEM CELL; UNITED KINGDOM;

CELL CULTURE TECHNIQUES; EUROPEAN UNION; EXPERT TESTIMONY; HUMANS; INTERNATIONALITY; JURISPRUDENCE; LEGISLATION, MEDICAL; NERVOUS SYSTEM DISEASES; PATENTS AS TOPIC; REGENERATIVE MEDICINE; STEM CELL RESEARCH;

EID: 80054115189     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.76     Document Type: Article

References (1)

1. Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the Legal Protection of Biotechnological Inventions.